Last 7 days
5.1%
Last 30 days
-4.5%
Last 90 days
-0.6%
Trailing 12 Months
-10.5%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
A | 40.8B | 6.8B | 0.60% | 4.89% | 32.54 | 5.96 | 8.37% | 3.64% |
ILMN | 36.7B | 4.6B | 17.13% | -33.44% | -8.34 | 8.02 | 1.28% | -677.95% |
MTD | 33.9B | 3.9B | 7.92% | 11.43% | 38.83 | 8.64 | 5.43% | 13.46% |
TECH | 11.7B | 1.1B | -0.96% | -31.21% | 44.48 | 10.41 | 8.77% | 24.82% |
MID-CAP | ||||||||
RGEN | 9.4B | 801.5M | -4.54% | -10.49% | 50.3 | 11.67 | 19.54% | 44.95% |
SMALL-CAP | ||||||||
PACB | 2.6B | 128.3M | 32.04% | 27.25% | -8.35 | 20.44 | -1.69% | -73.40% |
ADPT | 1.3B | 185.3M | 8.61% | -36.38% | -6.31 | 6.82 | 20.06% | 3.42% |
NSTG | 462.5M | 127.3M | 6.80% | -71.51% | -2.9 | 3.63 | -12.28% | -38.43% |
QTRX | 420.1M | 105.5M | 6.82% | -61.39% | -4.34 | 3.98 | -4.55% | -67.63% |
BNGO | 329.9M | 27.8M | -14.62% | -56.98% | -2.49 | 11.87 | 54.62% | -83.06% |
CDXS | 272.5M | 138.6M | -10.58% | -79.92% | -8.11 | 1.97 | 32.30% | -57.86% |
HBIO | 176.7M | 113.3M | 54.41% | -32.37% | -18.57 | 1.56 | -4.68% | -3204.17% |
CDXC | 114.1M | 72.0M | -6.71% | -37.80% | -6.91 | 1.58 | 6.82% | 39.11% |
CSBR | 54.5M | 54.1M | -13.17% | -50.55% | 504.68 | 1.01 | 21.80% | -72.38% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 0.0% | 802 | 801 | 779 | 734 | 671 |
S&GA Expenses | 0.5% | 216 | 215 | 209 | 199 | 184 |
R&D Expenses | 4.8% | 44.00 | 42.00 | 41.00 | 39.00 | 34.00 |
Costs and Expenses | -1.9% | 577 | 588 | 573 | 543 | 503 |
EBITDA | 7.5% | 271 | 252 | 248 | 220 | - |
EBITDA Margin | 7.5% | 0.34* | 0.31* | 0.30* | 0.30* | - |
Earnings Before Taxes | 9.0% | 219 | 201 | 195 | 179 | 154 |
EBT Margin | 9.0% | 0.27* | 0.25* | 0.25* | 0.24* | - |
Interest Expenses | -69.2% | 1.00 | 4.00 | 6.00 | 9.00 | 11.00 |
Net Income | 11.8% | 186 | 166 | 159 | 146 | 128 |
Net Income Margin | 11.8% | 0.23* | 0.21* | 0.20* | 0.20* | - |
Free Cahsflow | 37.8% | 87.00 | 63.00 | 45.00 | 46.00 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 2.5% | 2,525 | 2,463 | 2,445 | 2,384 | 2,358 |
Current Assets | 4.7% | 998 | 953 | 976 | 945 | 932 |
Cash Equivalents | -8.7% | 523 | 573 | 597 | 585 | 604 |
Inventory | -1.8% | 238 | 243 | 239 | 214 | 184 |
Net PPE | 9.4% | 191 | 174 | 168 | 148 | 125 |
Goodwill | 0.5% | 856 | 851 | 854 | 859 | 860 |
Liabilities | -2.1% | 614 | 627 | 640 | 617 | 608 |
Current Liabilities | -1.6% | 404 | 411 | 424 | 424 | 375 |
Shareholder's Equity | 4.1% | 1,911 | 1,835 | 1,805 | 1,766 | 1,750 |
Retained Earnings | 14.0% | 397 | 349 | 308 | 258 | 194 |
Additional Paid-In Capital | 0.4% | 1,547 | 1,541 | 1,534 | 1,529 | 1,572 |
Shares Outstanding | 0.1% | 56.00 | 56.00 | 55.00 | 55.00 | 55.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 7.7% | 172 | 160 | 141 | 133 | 119 |
Share Based Compensation | -2.7% | 27.00 | 28.00 | 29.00 | 29.00 | 28.00 |
Cashflow From Investing | -33.9% | -233 | -174 | -249 | -240 | -221 |
Cashflow From Financing | -3.9% | -13.34 | -12.83 | -14.20 | -11.57 | 1.00 |
67.7%
32.7%
19.2%
Y-axis is the maximum loss one would have experienced if Repligen was unfortunately bought at previous high price.
37.3%
29.9%
36%
20.4%
FIve years rolling returns for Repligen.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-24 | PALISADE CAPITAL MANAGEMENT, LP | reduced | -2.00 | -4,975,780 | 38,957,200 | 1.05% |
2023-03-23 | MetLife Investment Management, LLC | reduced | -2.01 | -738,731 | 5,782,610 | 0.05% |
2023-03-17 | American Portfolios Advisors | added | 0.17 | 29,136 | 218,170 | 0.01% |
2023-03-15 | B. Riley Wealth Advisors, Inc. | reduced | -2.14 | -59,136 | 448,864 | 0.01% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -66.97 | -15,233,900 | 6,495,070 | 0.01% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -0.12 | -15,000 | 145,000 | -% |
2023-03-06 | NORTH STAR ASSET MANAGEMENT INC | added | 3.01 | -1,073,480 | 14,743,500 | 0.92% |
2023-03-06 | Rockefeller Capital Management L.P. | new | - | 3,000 | 3,000 | -% |
2023-03-02 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | new | - | 5,757 | 5,757 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -0.23 | -378,569 | 3,518,430 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 15, 2023 | eddleman roy t | 4.87% | 2,705,689 | SC 13G/A | |
Feb 14, 2023 | price t rowe associates inc /md/ | 9.1% | 5,070,657 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.37% | 5,205,155 | SC 13G/A | |
Jan 23, 2023 | blackrock inc. | 11.0% | 6,123,594 | SC 13G/A | |
Sep 08, 2022 | blackrock inc. | 10.2% | 5,686,997 | SC 13G | |
Feb 14, 2022 | price t rowe associates inc /md/ | 5.5% | 3,042,655 | SC 13G | |
Feb 10, 2022 | vanguard group inc | 8.89% | 4,912,769 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 9.4% | 5,189,189 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 8.12% | 4,410,742 | SC 13G/A | |
Feb 05, 2021 | eddleman roy t | 6.65% | 3,500,000 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 96.61 -42.62% | 125.13 -25.68% | 240.22 42.68% | 394.48 134.31% | 633.95 276.54% |
Current Inflation | 88.66 -47.34% | 112.97 -32.90% | 211.21 25.45% | 341.26 102.70% | 542.87 222.45% |
Very High Inflation | 78.87 -53.15% | 98.29 -41.62% | 177.13 5.21% | 279.73 66.15% | 438.53 160.47% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 24, 2023 | PRE 14A | PRE 14A | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading | |
Mar 01, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-03 | KURIYEL RALF | sold (taxes) | -234,436 | 188 | -1,247 | senior vp, r&d |
2023-03-03 | Snodgres Jon | sold (taxes) | -690,712 | 188 | -3,674 | chief financial officer |
2023-03-03 | Bylund James | sold (taxes) | -39,480 | 188 | -210 | chief operating officer |
2023-03-03 | Hunt Anthony | acquired | - | - | 18,584 | chief executive officer |
2023-03-03 | Snodgres Jon | acquired | - | - | 8,795 | chief financial officer |
2023-03-03 | Gebski Christine | sold (taxes) | -23,688 | 188 | -126 | see remarks |
2023-03-03 | Bylund James | acquired | - | - | 625 | chief operating officer |
2023-03-03 | Gebski Christine | acquired | - | - | 375 | see remarks |
2023-03-03 | KURIYEL RALF | acquired | - | - | 3,591 | senior vp, r&d |
2023-03-03 | Hunt Anthony | sold (taxes) | -1,549,870 | 188 | -8,244 | chief executive officer |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands | 12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |||||||
Revenue: | |||||||||
Revenue | $ 801,536 | $ 670,534 | $ 366,260 | ||||||
Costs and operating expenses: | |||||||||
Cost of product revenue | 345,830 | 279,280 | 156,634 | ||||||
Research and development | 43,936 | 34,274 | 20,182 | ||||||
Selling, general and administrative | 215,829 | 183,866 | 119,621 | ||||||
Contingent consideration | (28,729) | 5,865 | 0 | ||||||
Total costs and operating expenses | 576,866 | 503,285 | 296,437 | ||||||
Income from operations | 224,670 | 167,249 | 69,823 | ||||||
Other (expenses) income: | |||||||||
Investment income | 6,978 | 176 | 1,741 | ||||||
Interest expense | (1,162) | (11,278) | (10,768) | ||||||
Amortization of debt issuance costs | 1,815 | 1,436 | 1,365 | ||||||
Other expenses | (9,531) | (1,168) | (214) | ||||||
Other expenses, net | (5,530) | (13,706) | (10,606) | ||||||
Income before income taxes | 219,140 | 153,543 | 59,217 | ||||||
Income tax provision (benefit) | 33,181 | 25,252 | (709) | ||||||
Net income | $ 185,959 | $ 128,291 | $ 59,926 | ||||||
Earnings per share: | |||||||||
Basic | $ 3.35 | $ 2.33 | $ 1.14 | ||||||
Diluted | $ 3.24 | $ 2.24 | $ 1.11 | ||||||
Weighted average common shares outstanding: | |||||||||
Basic | 55,460 | 55,015 | 52,554 | ||||||
Diluted | 57,455 | 57,264 | 53,892 | ||||||
Net income | $ 185,959 | $ 128,291 | $ 59,926 | ||||||
Other comprehensive income (loss): | |||||||||
Foreign currency translation adjustment | (17,508) | (18,971) | 17,112 | ||||||
Comprehensive income | 168,451 | 109,320 | 77,038 | ||||||
Products | |||||||||
Revenue: | |||||||||
Revenue | 801,183 | 670,319 | [1] | 366,136 | [2] | ||||
Royalty and Other Revenue | |||||||||
Revenue: | |||||||||
Revenue | $ 353 | $ 215 | $ 124 | ||||||
|
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 523,458 | $ 603,814 |
Marketable securities held to maturity | 100,299 | 0 |
Accounts receivable, net of reserves of $1,365 and $1,417 at December 31, 2022 and December 31, 2021, respectively | 116,247 | 117,420 |
Inventories, net | 238,277 | 184,494 |
Prepaid expenses and other current assets | 19,837 | 25,949 |
Total current assets | 998,118 | 931,677 |
Property, plant and equipment, net | 190,673 | 124,964 |
Intangible assets, net | 353,676 | 337,274 |
Goodwill | 855,513 | 860,362 |
Deferred tax assets | 840 | 1,903 |
Operating lease right of use assets | 125,023 | 101,559 |
Other noncurrent assets | 815 | 615 |
Total noncurrent assets | 1,526,540 | 1,426,677 |
Total assets | 2,524,658 | 2,358,354 |
Current liabilities: | ||
Accounts payable | 27,554 | 36,203 |
Operating lease liability | 6,957 | 8,303 |
Current contingent consideration | 13,950 | 0 |
Accrued liabilities | 71,120 | 75,498 |
Convertible Senior Notes, net | 284,615 | 255,258 |
Total current liabilities | 404,196 | 375,262 |
Deferred tax liabilities | 23,000 | 33,480 |
Noncurrent operating lease liability | 131,389 | 102,492 |
Noncurrent contingent consideration | 51,559 | 94,238 |
Other noncurrent liabilities | 3,814 | 2,815 |
Total noncurrent liabilities | 209,762 | 233,025 |
Total liabilities | 613,958 | 608,287 |
Commitments and contingencies (Note 12) | ||
Stockholders' equity: | ||
Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares issued or outstanding | 0 | 0 |
Common stock, $0.01 par value; 80,000,000 shares authorized; 55,557,698 shares at December 31, 2022 and 55,321,457 shares at December 31, 2021 issued and outstanding | 556 | 553 |
Additional paid-in capital | 1,547,266 | 1,572,340 |
Accumulated other comprehensive loss | (34,394) | (16,886) |
Accumulated earnings | 397,272 | 194,060 |
Total stockholders' equity | 1,910,700 | 1,750,067 |
Total liabilities and stockholders' equity | $ 2,524,658 | $ 2,358,354 |